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Functional magnetic resonance imaging (fMRI) is an essential workhorse of modern neuroscience, 
providing valuable insight into the functional organisation of the brain. The physiological 
mechanisms underlying the blood oxygenation level dependent (BOLD) effect are complex and 
preclude a straightforward interpretation of the signal. However, by employing appropriate 
calibration of the BOLD signal, quantitative measurements can be made of important physiological 
parameters including the the absolute rate of cerebral metabolic oxygen consumption or oxygen 
metabolism (CMRO2) and oxygen extraction (OEF). The ability to map such fundamental 
parameters has the potential to greatly expand the utility of fMRI and to broaden its scope of 
application in clinical research and clinical practice. In this review article we discuss some of the 
practical issues related to the calibrated-fMRI approach to the measurement of CMRO2. We give 
an overview of the necessary precautions to ensure high quality data acquisition, and explore 
some of the pitfalls and challenges that must be considered as it is applied and interpreted in a 





The brain relies predominantly on oxidative metabolism of glucose to satisfy its energy needs in 
the form of ATP supply (Verweij et al., 2007). Because the brain lacks any fuel reserves it requires 
a continuous supply of glucose and oxygen. Any disruption of this supply can significantly reduce 
the production of ATP and negatively affect brain health, with irreversible damage to brain tissue 
occurring within three minutes of cessation of blood flow (Safar, 1988). Understanding the 
diseases and mechanisms that can affect oxygen metabolism is of vital importance. The 
development of widely applicable methods that can measure the cerebral rate of oxygen 
metabolism (CMRO2) is, therefore, invaluable for the study of metabolic dysfunction.  
 
Over the last few years there have been a number of different MRI approaches proposed to make 
measurements related to oxygen metabolism, both globally (Jain et al., 2010; Lu and Ge, 2008; Xu 
et al., 2009) and at the tissue level (Bolar et al., 2011; Fan et al., 2015; Guo and Wong, 2012; He 
and Yablonskiy, 2007). In this review we focus our discussion on the calibrated fMRI methodology 
(Bulte et al., 2012; Gauthier et al., 2012; Gauthier and Hoge, 2013; Wise et al., 2013), which 
shows the potential to map oxygen metabolism at high spatial resolution and with a good level of 
sensitivity. Although still undergoing development as a technique, the methodology is currently 
being applied in a number of different diseases and results have been published in Alzheimer's 
disease (Lajoie et al., 2017a), carotid artery occlusion (De Vis et al., 2015), and in a 
pharmacological modulation study using caffeine (Merola et al., 2017b). These initial studies have 
revealed regional changes in CMRO2 that may provide useful insight into the progression of a 
disease, or action of a drug. This level of detail is clearly one of the key advantages of a tissue 
based approach, compared to a global measure, and has potential long-term clinical value in a 
wide range of conditions. The application of this methodology in disease brings new opportunities 
for understanding brain physiology, but also requires careful consideration of data acquisition, 
analysis and interpretation. Some disease states may violate fundamental assumptions of the 
model(s) applied to estimate the physiological parameters, whereas other problems may be 
overcome with appropriate data acquisition or modification of the analysis. Here we explore the 
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practical issues around data collection, analysis and interpretation with a view to providing 




The basis of dual-calibrated fMRI (dcfMRI), alternatively referred to as quantitative O2 imaging 
(Gauthier et al., 2012), is the modulation of blood flow, blood volume, and venous oxygenation 
during MR imaging via hypercapnic and hyperoxic gas challenges. Physiological models are used 
to calculate quantitative estimates of the absolute rate of cerebral metabolic oxygen consumption 
or oxygen metabolism (CMRO2) from the acquired data. The validity of these estimates is based 
upon a number of modelling simplifications and physiological assumptions. It is important to 
consider how these assumptions relate to the underlying physiology and the circumstances under 
which these assumptions hold when applying the technique. Fig. 1 shows a schematic of the 
vasculature and how the measured data relate to the underlying physiology. 
 
[Insert Fig. 1 near here] 
 
 
CMRO2 is linked to the vascular physiology by a complex interplay of physiological parameters. 
Under the assumption of passive diffusion of oxygen from the capillaries into the tissue, the rate of 
metabolism is dependent on the rate and pattern of blood flow through the capillaries, the capillary 
blood volume and its permeability to oxygen, the (arterial) oxygen content of blood entering the 
capillaries (CaO2), and the oxygen content in the tissue (CtO2) (Buxton and Frank, 1997; 
Jespersen and Ostergaard, 2012; Mintun et al., 2001; Vafaee and Gjedde, 2000; Valabregue et al., 
2003). However, the majority of these parameters are not directly accessible via MR imaging 
methods and inference on the rate of metabolism is instead made using the Fick principle (Fick, 
1870). The Fick principle relies on the conservation of mass, and states that the rate of metabolism 
can simply be determined via equation 1. Thus, in order to calculate a quantitative estimate of 
resting CMRO2 it is only necessary to measure baseline CBF, OEF and CaO2. Resting CBF can be 
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calculated from well-established arterial spin labelling (ASL) methods, while the resting OEF is 
extracted by analysing the modulated ASL and BOLD signals acquired during the dual-calibrated 
experiment. 
                   Equation 1. 
 
The ASL signal is sensitive to the transfer of labelled spins into the extravascular space through 
the arterioles and capillaries. By choosing an appropriate delay between tagging of the blood and 
imaging, it is expected that the intravascular contribution from the arterial blood volume (CBVa) is 
minimal and that the ASL signal is considered to be purely perfusion weighted (Buxton et al., 
1998). During a hypercapnic stimulus perfusion is increased, with the magnitude of this increase 
(in relation to the change in end-tidal CO2) being quantified by the cerebral vascular reactivity 
(CVR). For a hypercapnic stimulus CVR is principally determined by the dilatory response of the 
arteries and arterioles to the stimulus, i.e. an increase in CBVa (Kety and Schmidt, 1948; Reivich, 
1964). However, the BOLD signal is principally sensitive to changes in CBVv and CBVcap rather 
than CBVa (Ogawa et al., 1993). Therefore, when modelling the BOLD response to hypercapnia we 
need to estimate blood volume changes in the post-arteriolar vasculature. For simplicity, these two 
compartments are generally grouped together as one deoxyhaemoglobin sensitive blood volume 
(CBV in Fig. 1), which is a weighted sum of the capillary and venous compartments (dependent on 
their respective gradient-echo signal sensitivities and blood volumes). Although there is significant 
evidence of a variable and an active capillary dilation during functional hyperaemia (Itoh and 
Suzuki, 2012), current models assume that the blood volume response to hypercapnia is passive 
in the post-arteriolar network. Thus, ΔCBV is assumed to be proportional to ΔCBVa and is inferred 
from a simple power-law model of flow coupling to total blood volume (Grubb et al., 1974) (see 
equation 2). 
 
   
    
  
   
    
 
 
 Equation 2. 
 
where α is the ‘Grubb exponent’, and the subscript ‘0’ denotes the baseline state.  
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Of course, the BOLD signal is not just sensitive to the blood volume response to hypercapnia but 
also to the blood flow response via a change in the venous deoxyhaemoglobin content. To model 
the effect of an increase in perfusion on the BOLD signal it is important to know the metabolic 
response of the stimulus. Most researchers have assumed that the levels of hypercapnia used in 
calibrated fMRI are iso-metabolic, namely, blood flow is thought to increase without any alteration 
in metabolism (Chen and Pike, 2010a). Following the Fick principle of conservation of mass, the 
OEF must reduce in proportion to the CBF increase in order to maintain the baseline CMRO2. If the 
arterial deoxyhaemoglobin concentration [dHb]a is small then the venous deoxyhaemoglobin 
concentration [dHb]v is proportional to OEF, and the inverse of the fractional change [dHb]v is 
proportional to the change in flow (Hoge et al., 1999) (see equation 3). While not explicit in the 
modelling, the change in the BOLD signal will also be dependent on the change in [dHb]cap, which 
has been included in detailed BOLD signal models that have been used for model validation 
(Merola et al., 2016). 
 
   
    
 
       
      
 Equation 3 
 
Hyperoxic stimuli are considered in a similar manner to hypercapnic flow changes, in that they are 
treated as an iso-metabolic increase in oxygen availability (Chiarelli et al., 2007). If CBF is fixed 
while arterial oxygen content CaO2 is increased (by increased haemoglobin carried oxygen and 
oxygen dissolved in blood plasma), then via the Fick principle OEF must also be fixed to maintain 
baseline CMRO2. Thus, at steady state with fixed CBF, the arteriovenous O2 difference (CaO2 – 
CvO2) must equal the baseline value. Therefore, for any hyperoxic increase in CaO2 there will be 
an equivalent change in CvO2, from which the change in [dHb]v can be estimated. In reality, 
increases in arterial oxygen saturation (SaO2) are known to alter CBF. It is likely that this is 
principally a result of an associated reduction arterial partial pressure of CO2 (PaCO2) (Iscoe and 
Fisher, 2005), as animal studies demonstrate that when PaCO2 is fixed hyperoxia has no effect on 
CBF (Asher et al., 1988).  Equation 4 (Wise et al., 2013) links arbitrary changes in CBF and CaO2 
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to the BOLD signal; it incorporates CaO2 changes during CBF modulation and vice-versa. It is 
perhaps interesting to note that increases in CaO2 result in an approximately linear decrease in 
[dHb]v  that is mostly independent of its resting value, while changes in CBF result in a fractional 
change in [dHb]v. This fundamental difference between the two stimuli is what enables us to factor 




      
   




      
       
 
 
   Equation 4a 
 
      
       
 
    
   
 
 




       
    
   
              
    
   
     Equation 4b 
 
β is a field strength dependent term relating the BOLD signal to underlying vascular morphology 
and water diffusion, M is a calibration parameter representing a maximal BOLD response, φ is the 
O2 carrying capacity of haemoglobin (1.34 ml O2/gHb), [Hb] is the haemoglobin concentration in the 
BOLD sensitive vasculature, SvO2,0 is the percentage of oxygen bound to haemoglobin in the 
venous vasculature at baseline, [dHb]vo = [Hb](1-SvO2,0), and OEF = (CaO2 – CvO2)/CaO2. 
 
Applications of the Method 
The first published application of dcfMRI in neurodegenerative disease investigates the regional 
variation in oxygen metabolism in Alzheimer’s disease (AD) (Lajoie et al., 2017a), which is known 
to be associated with alterations in CMRO2 (Buckner et al., 2005). Consistent with earlier PET 
studies (Frackowiak et al., 1981; Fukuyama et al., 1994; Ishii et al., 1996; Tohgi et al., 1998) 
dcfMRI revealed a significantly reduced CMRO2 in the parietal lobe compared to controls. 
However, no correlation was found between the imaging parameters and the cognitive assessment 
scores (Montreal Cognitive Assessment). This study also highlighted an important dependence on 
arterial transit time for the accurate assessment of CMRO2 via dcfMRI. Regions with long transit 
times (e.g. occipital lobe) were shown to underestimate resting CBF and overestimate the change 
in CBF with hypercapnia. As a result, OEF and CMRO2 estimates in the occipital lobe were shown 
to be underestimated in both controls and AD patients. 
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A (more) rapid acquisition protocol, which consisted of 6.5 minutes of respiratory modulation, was 
used in the assessment of vascular disease in internal carotid artery occlusion (De Vis et al., 
2015). This pilot study sought to assess the ability of the method to detect variances in cerebral 
haemodynamics associated with the disease. However, the results showed no significant 
differences in CBF, OEF or CMRO2 between patients and controls, and a large variance in all 
measured parameters. Again, due to the sensitivity of the ASL signal to transit time effects, the 
issue of delayed transit time is a probable confound for the assessment of CMRO2 in vascular 
occlusion and other large vessel diseases. The authors note that use of velocity selective ASL 
(VSASL) could overcome these issues due to its inherent insensitivity to arterial transit time. 
Although conventional VSASL has a significantly reduced CNR compared to other tagging 
methods, more recent developments of the technique demonstrate superior GM SNR compared to 
conventional tagging approaches with moderate delay times (Guo and Wong, 2015). 
 
The use of dcfMRI in pharmacological studies has been investigated using caffeine in a cohort of 
healthy volunteers (Merola et al., 2017b). This study aimed to investigate the global (grey matter) 
and regional sensitivity of the method to simultaneous alterations in CBF and OEF. The results 
demonstrated a significant GM decrease in CBF and increase in OEF, with regional decreases in 
CMRO2. These reductions in CMRO2 are consistent with previous PET-FDG results (Park et al., 
2014), although are at odds with some MRI studies, which have shown both increases (Griffeth et 
al., 2011) and no change (Xu et al., 2015) in CMRO2 with caffeine. The data presented by Merola, 
Xu, and Griffeth all used similar doses of caffeine, 200-250mg. The observed increase in global 
OEF reported by Xu et al. is similar to that reported by Merola et al., 18.6% versus the 16%. 
However, the global CBF reduction (16.4%) reported by Xu et al. is significantly less than the 30% 
grey matter reduction observed by Merola et al. and the 27% reduction observed by Griffeth et al.  
Thus, the results of the proof-of-principle study from Merola et al. present a view of a regional 
variation of CMRO2 where the changes in CBF and OEF are consistent with alternative acquisition 
methods. However, we would highlight the need for further comprehensive validation studies using 




Sensitivity to physiological assumptions 
 
Due to the reliance on hypercapnic and hyperoxia gas challenges many of the assumptions that 
influence a conventional calibrated bold experiment also affect the dual-calibrated approach, (see 
(Hoge, 2012) for a review). Here we discuss the detail of the principal confounds from the 
perspective of the dual-calibrated approach. As previously noted there is the fundamental 
requirement in calibrated BOLD experiments that the hypercapnic and hyperoxic stimuli do not 
alter oxygen metabolism. Meeting these conditions means that the ASL signal and the arterial 
oxygen content can be used to infer the [dHb]v changes caused by the stimuli. A number of studies 
(Chen and Pike, 2010a; Xu et al., 2011) have investigated the validity of this fundamental 
assumption in healthy volunteers and while there is conflicting evidence regarding the effect of mild 
hypercapnia on oxygen metabolism, any changes is metabolism are generally assumed to be 
small for the stimuli used in calibrated fMRI experiments. However, any changes in metabolism 
during hypercapnia or hyperoxia can have a significant influence on OEF (and thus CMRO2 
estimates); see simulations in (Merola et al., 2016). 
 
When using calibrated methods to investigate drugs or disease there are a number of physiological 
conditions under which significant changes in metabolism are possible or even likely. For example, 
where oxygen metabolism is suppressed due to limited oxygen delivery any increase in CBF or 
CaO2 is likely to be coupled with an increase in metabolism, e.g. in stroke or other diseases where 
metabolism is restricted due to reduced perfusion. Additionally, many of the conditions that we 
would like to study may suffer from hypo-metabolism due to limited oxygen supply, rather than 
mitochondrial dysfunction (where we may not expect alterations in metabolism due to increased 
supply). The oxygen supply may be restricted either by limited perfusion, restricted diffusion of 
oxygen into the tissue, or a combination of both. It is unclear exactly how these restrictions to 
oxygen delivery and the metabolic rate of oxygen consumption will interact with hypercapnic and 
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hyperoxic stimuli, thus care must clearly be taken as this new methodology is exploited to 
investigate metabolic dysfunction. 
 
The flow-volume relationship described by equation 2 is based on empirical data measured in 
animal studies (Grubb et al., 1974) and later re-produced in human volunteers (Chen and Pike, 
2010b). Its use in the model and analysis generally assumes a fixed and uniform functional 
relationship between CBF and venous volume changes. However, to the best of our knowledge 
this relationship has not been studied in disease or altered states of physiology where such 
assumptions may no longer hold. Indeed, the flow-volume relationship could vary across healthy 
tissue, change with alterations in baseline conditions (e.g. if a subject has increased/reduced 
perfusion pressure), or be affected by focal disease. This shortfall has been well recognized by the 
imaging community and proposals have been made to map volume-flow coupling during a dcfMRI 
experiment (Wise et al., 2013). However, as demonstrated by Merola et al. (Merola et al., 2016) 
the co-linearity in the models between α and another vascular parameter, ‘β’, (which relates the 
BOLD signal to the vascular morphology) means that these parameters are not separable by the 
proposed implementation. Alternative methods have also been proposed to measure the vascular 
morphology during a dcfMRI examination (Germuska and Bulte, 2014), where vessel size imaging 
information is simultaneously acquired with the addition of a spin-echo readout. Incorporation of 
such information could resolve the co-linearity problem and allow direct estimation of α. However, 
vessel size data is inherently noisy and such an experiment would require careful optimization of 
the acquisition protocol to avoid the propagation of noise in the analysis. 
 
The assumption of a fixed flow-volume relationship could potentially create even greater issues as 
the method is implemented at higher resolution, as is now practicable with the increased 
availability of ultra high field scanners. As the resolution is increased the assumption that ASL 
perfusion changes are co-localised with BOLD sensitive CBV changes may not hold. This is 
particularly relevant if attempting to map CMRO2 through the cortical layers, where significant CBF 
changes may no longer occur in the same voxels as the relevant BOLD CBV changes, and thus 
the effective alpha may change significantly between voxels and across layers. Furthermore, 
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careful consideration needs to be given to the fundamental assumption of the conservation of 
mass used in the derivation of the BOLD equations. If the measured CBF changes are no longer 
co-localised with the associated venous oxygenation changes then this assumption is no longer 
valid and the Fick relationships underpinning the method are not relevant.  
 
A common assumption when implementing these methods is that a systemic measure of 
haemoglobin concentration [Hb] at or near the time of examination is a reliable estimate of the 
cerebral [Hb] in the venous vasculature. While this is likely to be a good approximation at rest, and 
minimal differences in the closely related parameter, haematocrit (Hct), have been found across 
grey matter in healthy volunteers, there is evidence showing significant regional changes in Hct 
during disease progression (Loutfi et al., 1987) and (Okazawa et al., 1996). The change in Hct, 
and therefore [Hb], appears to be due to a change in the plasma concentration of the blood, which 
may be compensated for by an increase in OEF (Okazawa et al., 1996). The plasma concentration 
(and blood velocity) is also the principal driver for the difference between large and small vessel 
Hct via the Fahraeus effect (Gaehtgens, 1981). Thus, regional differences in Hct can also be 
expected due to variation in small vessel volume (which may also be altered dynamically via 
vasodilation). Without correction for these effects, such changes in haemoglobin concentration 
would be misinterpreted as a change in CMRO2. A potential MRI method to map resting cerebral 
Hct has been proposed (Calamante et al., 2016) that requires the additional acquisition of a 
dynamic susceptibility contrast DSC-MRI dataset (whose parameter estimates are Hct weighted). 
While such additional data acquisitions could limit the applicability of the technique, it may be 
necessary in certain disease states and may offer additional scope to extend the modelling and 
analysis of the calibrated data.  
 
 
Blood Gas Modulation for calibration 
 
Here we describe the practical set-up for the manipulation of end-tidal gases and present different 
approaches for gas manipulation and data collection when performing dcfMRI (Fig. 2, Tables 1 and 
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2). There are two fundamental approaches to modulating end-tidal gases, fixed inspired fractions 
and targeted end-tidal changes. End-tidal targeting may either be prospective (Ito et al., 2008) or 
dynamic (Wise et al., 2007), that is, gas changes can be pre-calculated (depending on individual 
physiology) or updated in real-time (or a combination of the two). The simplest form of dynamic 
end-tidal targeting employs manual control of flow meters to adjust gas delivery relying on skilled 
experimenters to adjust the inspirate. However, automated methods have also been proposed 
(Wise et al., 2007). Dynamic adjustment of gas delivery requires a short sampling lag, which 
necessitates a short sampling line between the subject and gas monitor. Due to the restrictions of 
the MR environment this can be difficult to achieve and particularly in the case of automated 
methods can lead to instability in end-tidal traces. However, newer commercial systems are 
becoming available that seek to address this issue by employing an MR compatible gas analyser 
in the scan room. In the interest of simplicity, and to avoid some of the issues associated with end-
tidal targeting, a more straightforward approach is to simply deliver pre-defined concentrations of 
gases. Again, this may either be achieved manually or under computer-automated control.   
 
In principle, the accurate targeting of end-tidal CO2 (PETCO2) or O2 (PETO2) is the preferred method. 
As discussed in the modelling section, the change in venous oxygen concentration (CvO2) due to 
an oxygen challenge is directly related to the change in CaO2, and thus PaO2. If the alveolar-
arterial oxygen tension difference is small, as is expected in the absence of compromised gas 
exchange function of the lungs, then PETO2 is a reliable estimate of PaO2 (Bengtsson et al., 2001). 
Therefore, targeted modulation of PETO2 in fact allows for a controlled and repeatable modulation 
of CvO2. By similar reasoning, because CBF is monotonically related to steady-state PaCO2 
(Shapiro et al., 1966), targeted increases in PETCO2, allow for controlled and repeatable increases 
in CBF (with the magnitude of change in CBF determined by the local CVR). Additionally, a well-
controlled experiment that uses end-tidal targeting can allow for the modulation of one gas while 
clamping the level of another, e.g. modulation of O2 while holding end-tidal CO2 constant. This is a 
potentially useful function that can simplify the analysis somewhat and may help to increase the 
reliability of experiments. Fig. 2a shows a schematic of the experimental set-up for a calibrated 
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For a typical fixed inspired experiment, an interleaved paradigm is used with an inspired oxygen 
fraction (FiO2) of 50% and an inspired CO2 fraction of 5%. The choice of FiO2 is determined by a 
trade-off between maximising the BOLD response in hyperoxia and avoiding significant artefacts 
from paramagnetic molecular O2 in the airways and sinuses, T1-shortening effects that may affect 
CBF quantification, and any potential alteration in metabolism. However, there is still debate about 
the appropriate level and whether greater inspired fractions are a practical alternative (Lajoie et al., 
2017b). The choice of 5% for the CO2 challenge is mainly dictated by patient comfort and the need 
for an iso-metabolic challenge. A 5% CO2 stimulus is well tolerated by the majority of subjects both 
in our experience and more generally (Lajoie et al., 2016). However, we would advise that any CO2 
challenge be trialled on naive subjects outside of the scan environment, allowing them to become 
accustomed to the sensation of elevated PaCO2 prior to any scan session. In our experience 
typical end-tidal gas changes for such fixed inspiration experiments range from approximately 200-
300 mmHg for the O2 stimulus and approximately 8-12 mmHg for the CO2 stimulus, depending on 
the participant’s ventilatory response. When using targeted gas delivery, values that lie in the 
centre of these ranges are typically chosen. Mapping of CVR performed with a CO2 stimulus is an 
associated method that has been performed safely in hundreds of patients and volunteers. In 2013 
a review of the safety and tolerability of CVR scanning performed in 434 CVR examinations (294 
patients) was published (Spano et al., 2013). In all cases a targeted end-tidal change of 10 mmHg 
was prescribed (from 40 mmHg at baseline up to 50 mmHg during hypercapnia). The protocol 
included 45 second and 130 second blocks of hypercapnia interleaved around a 90 second 
baseline, age range of participants 9-88 years old (mean 45.9 years ± 20.6). Transient symptoms 
during the hypercapnic phase were reported in 11.1% of patients, these symptoms included 
shortness of breath, headache, and dizziness; fewer than 6% of all subjects withdrew due to such 
symptoms. There were no lasting effects due to the intervention and no major complications. 
Systematic evaluations of tolerability for dcfMRI protocols have not yet been undertaken, however, 
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the determining factor is likely to be the level and duration of hypercapnic stimuli used during the 
examination, and reported findings of tolerability agree well with the experience of CVR 
examinations. Using a fixed inspiration protocol (5% CO2 and 50% O2) dcfMRI was performed in 
34 Alzheimer’s patients (mean age 76.9 years ± 6.5) and 37 controls (mean age 74.4 ± 4.6) (Lajoie 
et al., 2017a). During hypercapnic testing 10% of controls and 17% of patients withdrew. As 
highlighted in their manuscript, the elevated dropout rate for controls is probably associated with 
increase age of the participants, whereas the greater dropout rate for AD patients may be 
associated with the disease.  
 
 
Some of the principle concerns when delivering gas mixtures to a participant are to ensure there is 
low resistance in the breathing circuit, sufficient supply to match peak inspiration, minimal dead 
space (to reduce re-breathing of expirate) and accurate monitoring of end-tidal gases. Additionally, 
it is important to consider the failure mode of the circuit, i.e. what will the subject breath if there is 
an interruption in the gas supply. There are different ways to address these concerns, with more 
options available when end-tidal values are not being controlled (as this requires tight control of 
inspired fractions, Table 1). The most straightforward method to deliver and record gases is the 
use of a dual nasal cannula, which allows the delivery of gas to both nostrils while simultaneously 
sampling the expirate. This method is inherently low resistance, has no dead space and is capable 
of providing accurate monitoring of end-tidal gases. However, each breath of inspired gas will be a 
mixture of room air and that delivered by the cannula, limiting the maximum deliverable 
concentrations. Additionally, practical experience shows that it is easy for the placement of the 
cannula to move during an experiment, restricting delivery and potentially providing inaccurate 
monitoring of end-tidal gases. A common alternative is to use an MRI compatible mask with an 
appropriate breathing circuit. If the breathing circuit is properly designed, a well performing and 
reliable system is achievable using off the shelf components. One such breathing circuit has been 
proposed by Tancredi et al. (Tancredi et al., 2014). The circuit uses a combination of valves to 
provide a minimal dead space and a small reservoir to meet peak inspiratory requirements, while 
simultaneously allowing breathing of room air in the failure mode. With the addition of low 
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resistance filters on the gas inlet and sample outlet, this circuit forms the basis of the breathing 
system we use for the majority of our current gas modulation studies. 
 
In addition to the delivery method, the experimental design or gas paradigm, can have a significant 
effect on the quality and interpretability of the experiment. The simplest paradigm, and probably 
most utilized so far, is the interleaved design. With this method periods of baseline (air) are 
interleaved with O2 and CO2 block challenges (Fig. 2b), sometimes with pre/de-emphasis added to 
the O2 blocks to speed transition from baseline to stable hyperoxia (Germuska et al., 2016). 
Modelling studies, based upon dual-echo PASL data, suggest that the error in CMRO2 estimates is 
minimised with approximately equal time spent in each state, that is baseline, hyperoxia, and 
hypercapnia (Germuska et al., 2014). While the optimal gas paradigm is likely to change 
depending on end-tidal targets, FiO2, FiCO2, and acquisition scheme (e.g. PASL, pCASL, 
background suppression, single echo readout, or dual-echo readout, Fig. 2b and Table 2) this 
equally weighted paradigm is likely to be a robust design for most approaches. An alternative to 
the interleaved design is the simultaneous design, where O2 and CO2 end-tidal values are 
modulated at the same time. The principle advantage of this approach is the possibility to encode 
more physiological data into the experiment. While the interleaved design is essentially composed 
of two experiments (an O2 challenge and a CO2 challenge) the simultaneous design can be 
thought of as multiple experiments, with each experiment consisting of different levels of O2 and 
CO2 modulation. The extra information provided by these paradigms can potentially be used to aid 
in fitting of the data (Gauthier et al., 2012) or to extract extra parameters from the data (Wise et al., 
2013). However, when using a simultaneous gas paradigm it is necessary to consider any potential 
contrast-to-noise (CNR) ratio sacrifices that are made, e.g. if using O2 or CO2 challenges that are 
less than the maximum allowable. 
 
[insert Fig. 2 and Tables 1 and 2 near here] 
 
 
MRI Data Acquisition and Analysis 
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Fig. 2b depicts idealised respiratory traces and expected MR signals for an interleaved dcfMRI 
experiment. As shown in the diagram, it is necessary to simultaneously acquire both CBF and 
BOLD weighted data in order to solve for the resting CMRO2. Here we identify and compare (Table 
2) three principle methods of data acquisition, single-echo ASL (Bulte et al., 2012), dual/multi-echo 
ASL (Gauthier et al., 2012; Germuska and Bulte, 2014; Wise et al., 2013), and dual-excitation ASL. 
In each of these methods the ASL data can be acquired either using a pulsed (PASL), continuous, 
or more often, pseudo-continuous (pCASL) tagging scheme. As in any ASL acquisition, the CNR 
advantages of pCASL acquisition schemes offer a significant advantage over PASL methods. 
However, due to systemic alteration in CBF caused by hypercapnia, the effect of inversion 
efficiency changes may pose a greater challenge in the analysis of calibrated fMRI than in 
conventional acquisitions.  
 
The most straightforward data acquisition method is to use a single-echo readout as employed in a 
traditional ASL scanning. However, the echo time is increased to somewhere in the region of 20 
ms to increase the BOLD weighting. This method has the clear advantage of easy implementation 
and acquires the BOLD and CBF data simultaneously. However, the CNR of both the ASL and 
BOLD data is limited due to a compromise in echo times that is sub-optimal for both ASL and 
BOLD acquisitions. Additionally, application of background suppression (which can significantly 
increase ASL CNR) is likely to significantly reduce the BOLD CNR, and so to the best of our 
knowledge has not been employed for single-echo readouts. To overcome the compromise of 
choosing a single echo time a number of studies have employed a dual-echo readout, where a 
second BOLD-weighted echo is readout immediately following the ASL readout. The advantage of 
this acquisition scheme is that an optimal echo time can be chosen for each echo, creating a 
predominately CBF-weighted echo and a predominately BOLD-weighted echo. The main 
disadvantage of this approach compared to the single-echo readout is the increased readout time 
per slice. This increase in readout time means that for the same number of slices there will be a 
significant increase in the spread of post labelling delay times from inferior to superior slices 
(assuming bottom up acquisition of the data). This increase in the range of post labelling delay 
 17 
times will manifest either as an increase in arterial contamination (in inferior slices) or as a 
reduction in CNR (in superior slices), or a combination of the two. The application of background 
suppression will again have a significant negative influence on the BOLD CNR. However, because 
of the increased BOLD-weighting it may be possible to include a moderate amount of background 
suppression and still retain sufficient BOLD CNR. The final acquisition method currently used to 
acquire dcfMRI data is the dual-excitation acquisition scheme. This acquisition scheme essentially 
employs interleaved ASL and BOLD acquisitions. After each ASL tagging/control period a volume 
of CBF-weighted data is acquired (as in a conventional ASL scan), which is then quickly followed 
by the acquisition of a BOLD-weighted volume. The acquisition scheme is less temporally efficient 
than the dual-echo scheme, requiring an extra 100-300ms per TR to acquire the same volume of 
data. Additionally, there will be approximately 500-1000ms difference between the acquisition time 
of the CBF-weighted data and BOLD-weighted data (depending on sequence parameters). Despite 
these limitations, there are a number of advantages of acquiring the data in this manner. Because 
the readout time per slice is the same as the single-echo readout, the sequence is well suited to 
full brain coverage, not suffering from the same degree of arterial contamination or reduced CNR 
in superior slices associated with dual-echo readouts. Furthermore, standard background 
suppression methods can be employed to greatly increase the CNR of the ASL data without 
significantly affecting the CNR of the BOLD readout (Schmithorst et al., 2014). In our experience 
the ability to employ background suppression in a dual-excitation acquisition outweighs the 
disadvantages of the approach, producing good quality CMRO2 maps across the grey matter. Fig. 
3 shows example CMRO2 maps obtained in an individual volunteer using an 18-minute dual-
excitation pCASL acquisition with background suppression applied as described in (Okell et al., 
2013) (TR 4.4 seconds, TEASL 10ms, TEBOLD 30ms, tagging duration 1.5 seconds, post-labelling 
delay 1.5 seconds, GRAPPA acceleration factor of 3, 3.4x3.4x7mm voxels, 20% slice gap, 16 
slices, respiratory stimulus as described in (Germuska et al., 2016)). 
 
 




Because the dual-calibrated method is still undergoing development there is yet to be any 
consensus regarding data analysis. From the point of view of data modelling there are two 
principle approaches, the separate hypercapnia and hyperoxia method proposed by Bulte et al. 
(Bulte et al., 2012) and the combined or generalised calibration method described by Gauthier et 
al. (Gauthier and Hoge, 2013) and Wise et al. (Wise et al., 2013). The method proposed by Bulte 
et al. has the advantage of being straightforward and easy to implement. However, as previously 
highlighted (Hoge, 2012), it can result in errors in the estimation of OEF when arterial saturation 
drops below approximately 95% (due to the implicit assumption of 100% saturation in the models). 
Additionally, the generalised calibration model(s) allow for the assessment of arbitrary and 
simultaneous changes in arterial CO2 and O2. This is useful for a number of reasons, enabling the 
analysis of more complex gas modulations (Wise et al., 2013), or for the analysis of the complete 
acquisition time series (Germuska et al., 2016). When analysing the entire data time series, 
parameter estimates and end-tidal respiratory traces are fed through the generalised model to 
obtain a best fit to the acquired data. Although this approach increases the complexity of the 
analysis, modelling studies and in-vivo acquisitions suggest that such an approach makes better 





As dcfMRI is applied to a wider variety of populations and patient groups it is essential that the 
repeatability of the method is characterised and taken into consideration when interpreting results 
of longitudinal studies, performing statistical power calculations, or identifying regional alterations 
in metabolism. So far data has been presented on the repeatability from two small groups of 
healthy volunteers, (Lajoie et al., 2016) n=8 and (Merola et al., 2017a) n=12. The results from 
these studies show modest repeatability of within subject grey matter (GM) parameters. With 
Lajoie et al. reporting GM coefficient of variations of 3.9%, 13.6%, and 15.2% for resting CBF, 
OEF, and CMRO2 respectively. Merola et al. found similar results with GM coefficient of variations 
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of 6.9%, 6.7%, and 12.0% respectively. Additionally, the investigation by Merola found that nearly 
all subjects had an ICC of greater than 0.6 (generally classified as ‘good)’ for the voxel-wise 
correlation of CMRO2 values both within session and across days. The repeatability of GM 
estimates is somewhat comparable with PET measures of repeatability, which report GM 
coefficient of variations of 8.8%, 9.3%, and 5.3% (for CBF, OEF, and CMRO2 respectively) 
(Bremmer et al., 2011) and 4.6%, 2.1%, and 3.7% (Coles et al., 2006). However, the time to 
acquire the data is significantly shorter, 18 minutes for MRI data acquisition versus approximately 
45 minutes for the PET acquisitions. Additionally, the dcfMRI methodology removes the need for 
ionising radiation, arterial blood sampling and the onsite cyclotron necessary to perform a 15O PET 
examination. The high ICC reported for the voxel-wise analysis is encouraging as it demonstrates 
good repeatability of voxel-wise estimates on a per subject basis. This is important if the method is 
to be used to assess regional changes either as a result of disease or due to an intervention.  
 
In addition to the repeatability of the method, the sensitivity and accuracy of the method are key 
factors in determining its usefulness as a biomarker. A repeatable measure with a high level of 
sensitivity can be used to identify sub-groups or for the assessment of individual patients rather 
than just reporting average or group effects, while a high level of accuracy ensures that the 
parameters are biologically interpretable and can help in our scientific understanding of the 
condition being studied. Although there have been no comprehensive investigations of the 
method’s sensitivity, the initial findings are encouraging. Investigations in Alzheimer's disease 
(Lajoie et al., 2017a) demonstrated a significant reduction in OEF within the parietal lobe (voxel-
wise analysis), and an investigation on the effects of caffeine (Merola et al., 2017b) found a 
significant GM increase in OEF with regional reductions in CMRO2. The accuracy of the method 
has been investigated in a study undertaken by Fan et al. (Fan et al., 2016), who compared 
calibrated measures of OEF against a susceptibility based MR imaging method in eleven healthy 
volunteers. The data were compared in terms of the agreement between techniques, and in the 
ability of baseline measurements to predict CBF responses to visual stimulation. The reported data 
shows reasonable agreement between the two methods (R2 = 0.39) and similar correlations 
between resting OEF and the visual CBF response, R2 = 0.37 and 0.36 for the calibrated and 
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susceptibility based methods respectively. Additionally, investigations in healthy volunteers 
(Germuska et al., 2016) showed a strong negative correlation (R2 = 0.66) between resting CBF 
and OEF, which are comparable with whole brain measures by Lu et al. (Lu et al., 2008). Thus, 
demonstrating the expected coupling between these two parameters and demonstrating the ability 
of the technique to detect variation in both measured and derived parameters in individual 
subjects. Although these initial findings are promising, there is still a clear need for further 
investigation with specific interventions and conditions to provide more quantitative information on 
the sensitivity and accuracy of the method. 
 
Prospects 
The aim of dcfMRI is to offer an alternative method to 15O PET for the quantitative mapping of 
cerebral oxygen metabolism. In principle dcfMRI offers several advantages including availability, 
acquisition time, and reduced risk (lack of ionising radiation). Due to the lack of ionising radiation, 
repeat examinations can be carried out without significant risk to participants, thus this opens the 
door for longitudinal studies to assess changes in baseline metabolism. This is a significant 
advantage compared to PET imaging of CMRO2, and we anticipate a significant role for dcfMRI in 
this area. Another potential advantage of the technique is its multi-parametric nature, for example it 
inherently provides extra vascular information in the BOLD and ASL CVR parameters, and 
provides information on the dHb weighted blood volume via the oxygen gas modulation. 
Additionally, it is straightforward to incorporate additional MRI contrasts that could be used to tease 
out further metabolic or vascular information (Germuska and Bulte, 2014), or potentially increase 
the robustness of the technique. 
 
Over the last 3-4 years a number of groups have already taken up the method and are looking at 
disease, drug and age related changes in metabolism. Some of the results from these studies 
show considerable promise for the technique, but they also highlight some of the technical 
challenges related to the measurement. The principal technical challenge appears to be the robust 
measurement of CBF. Because the CBF measurement is based on ASL, any restrictions and 
challenges that apply to ASL also apply to dcfMRI. Therefore, for example, accurate measurement 
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of CMRO2 is challenging in the presence of long arterial transit times. In order to overcome these 
challenges, ASL free methods of calculating the BOLD calibration parameter M have been 
proposed (Blockley et al., 2015; Blockley and Stone, 2016). These methods, based on the 
measurement of basal R2’, remove the need for a CO2 gas challenge and thus avoid the need to 
measure small changes in the ASL signal. However, because these methods are based on the 
resting R2’ value, rather than an oxygenation dependent signal change, they are sensitive to 
additional sources of susceptibility such as myelin content or iron deposits. This is a significant 
challenge for such techniques and further developments are required if this confound is to be 
overcome. Nevertheless, the incorporation of such techniques into the calibrated fMRI framework 
has the potential to increase the robustness and applicability of the technique, allowing its 
application in cohorts where a CO2 gas challenge may be contraindicated or unfeasible. 
Undoubtedly, through the use of such methods and other developments in data acquisition and 
analysis such those that we have shown to experimental design and estimation procedures, the 
calibrated fMRI techniques will continue to improve and will find novel application in the 
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Fig. 1. Cerebral vascular schematic showing the relationship between parameters that are 
measured or estimated (outer ellipse), by the experimental methods under consideration, and the 
underlying tissue physiology (inner ellipse) that is not measured or estimated. Arterial oxygen 
saturation (SaO2) and arterial oxygen content (CaO2) may be calculated from the partial pressure 
of end-tidal oxygen (PETO2). Cerebral blood flow (CBF) is measured using arterial spin labelling in 
which the magnetic label is applied to the water in arteries and then interrogated once it diffuses 
into the tissue compartment (spin label). Cerebrovascular reactivity (CVR) is derived from changes 
in CBF in response to changes in the partial pressure of end-tidal carbon dioxide (PETCO2).  
Cerebral blood volume (CBV), cerebral metabolic rate of oxygen consumption (CMRO2) and 
oxygen extraction fraction (OEF) are key parameters that are estimated. Compartmental properties 
include the arterial, capillary and venous blood volumes (CBVa,cap,v), arterial, capillary and venous 
deoxyhaemoglobin concentrations ([dHB]a,cap,v), venous oxygen content (CvO2) and tissue oxygen 
content (CtO2). 
 
Fig. 2. Schematic of respiratory manipulations needed for calibrated fMRI (a and b) and the 
corresponding idealised BOLD and CBF time-courses (b). Typical experimental duration and 
respiratory manipulations are indicated. See also Table 1 for a description of respiratory 
manipulations and Table 2 for a description of MR acquisition strategies.  
 
Fig. 3. Example CMRO2 parameter maps acquired from a single subject using a dual-excitation 










Table 1. The advantages and disadvantages of different respiratory challenge implementations for 
the modulation of cerebral blood flow and oxygenation, necessary steps of the calibration of fMRI 
signals. 




Convenient and comfortable, 





Easy to perform, low cost. Can 
be made more consistent with 
automated control. 
Face mask less convenient. 
End-tidal values not targeted 
- depend on ventilatory 
response, slower transitions. 
Prospective end-
tidal targeting (with 
face mask) 
 
Complex end-tidal waveforms 
achievable. Can be performed 
by automated/expert manual 
control. Fast transitions. 
Expensive and complex 
control system required for 
automated control. Lack of 
feedback may result in drift 
of end-tidal values. 
Feedback-based 
dynamic end tidal 
targeting (with face 
mask) 
Complex end-tidal waveforms 
achievable. Can be performed 
by automated/expert manual 
control. Fast transitions. 
Expensive and complex 
control system required for 
automated control. Feedback 




Table 2. The advantages and disadvantages of different schemes for MR signal acquisition in 
dual-calibrated fMRI for the assessment of OEF and CMRO2. 
 
Method Pros Cons 
Single echo ASL Widely available, shortest 
TR, shortest total ASL 
volume readout (good 
coverage) 
Compromised (non optimal) 




Dual echo ASL Optimal ASL signal 
(especially with short TE 
spiral readout) and BOLD 
contrast from the later echo 
Less widely available,; longer 
volume readout (e.g. 
reducing ASL signal in 
superior slices); background 
suppression would 
compromise BOLD. 
Dual Excitation ASL 
(alternate ASL, BOLD 
volumes, minimizing 
TR) 
Optimal ASL signal especially 
with background 
suppression, short ASL 
volume readout (good 
coverage), good BOLD CNR. 
Longer TR; ASL and BOLD not 
acquired simultaneously, 
BOLD CNR slightly 
compromised by BG 
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